Followers | 53 |
Posts | 3489 |
Boards Moderated | 0 |
Alias Born | 02/05/2014 |
Wednesday, April 15, 2015 7:45:10 PM
As soon as the volume of available 1's for sale runs low, the market makers pile another batch on the ask. Their objective is not to make a profit on the sale. They have already been paid a fee to handle this selloff. Their objective is simply to get retail buyers to continue to buy more shares.
The good news is that eventually the financiers will have sold enough shares to pay off DNA's debt. At that point, perhaps the financiers, or someone else, will provide DNA management with the funding required to bring their new product to market. Because Mel told another iHub poster last week that DNA still no funding for the new product, it is easy to see that funding availability for a new product has probably been restricted until DNA first clears their existing debt.
So, if you can afford to risk the loss, I encourage you all to buy more shares of DNAX. ; )
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM